Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19609242 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients
Condition: Malignant Melanoma
Interventions: Biological: mRNA;   Drug: GM-CSF s.c.

Indicates status has not been verified in more than two years